Price T Rowe Associates Inc Eton Pharmaceuticals, Inc. Transaction History
Price T Rowe Associates Inc
- $816 Billion
- Q1 2024
Shares
3 transactions
Others Institutions Holding ETON
# of Institutions
45Shares Held
7.12MCall Options Held
52.7KPut Options Held
0-
Opaleye Management Inc. Boston, MA2.45MShares$8.05 Million2.23% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.03MShares$3.38 Million0.0% of portfolio
-
Acuitas Investments, LLC580KShares$1.91 Million1.15% of portfolio
-
Westside Investment Management, Inc.574KShares$1.89 Million0.52% of portfolio
-
Paradigm Capital Management Inc300KShares$987,0000.05% of portfolio
About Eton Pharmaceuticals, Inc.
- Ticker ETON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,297,000
- Market Cap $83.2M
- Description
- Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...